Wedbush Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)
at www.tipranks.com (Mon, 22-Dec 8:36 AM)
ARTV Receives FDA Fast Track for First-in-Class B-Cell Depleting Therapy in Refractory RA—Upcoming Data May Set Stage for Pivotal Trial
Market Chameleon (Fri, 17-Oct 9:53 AM)
